RxDoctor Payments Data

David Haley

Foot & Ankle Surgery · Wilmington, DENPI 1750371159

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.5% of the total across 141 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 41 manufacturers reported payments, led by Ossio Inc at 30.1% of the total. Reporting peaked in 2021 at $2,236 and has fallen 60.4% since, to $886 in 2025.

$6,104in general payments, 2019–2025

Across 141 payments — averaging $43.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ossio Inc$2K
  • Stryker$765
  • Smith+Nephew$665
  • Medtronic$436
  • Sandoz$321
  • Osteomed LLC$289
  • plus $2K from 35 others

What the payments were for

  • Food & beverage$6,01599%
  • Education$891%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,104 in reported general payments places this provider in the 70th percentile of 32 foot & ankle surgery providers in Delaware.

See all foot & ankle surgery providers in Delaware

Medicare billing

Part B allowed, 2024
$222,283
Medicare patients
725
Services billed
2,397

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib33$1,577
Econazole Nitrate26$930
Mupirocin60$443
Ketoconazole19$412
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen48$379
Gabapentin29$350
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip15$339
Terbinafine Hcl23$282
CefuroximeCefuroxime Axetil12$180
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$138

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Wilmington

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →